| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/01/2002 | WO2002058673A1 Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine |
| 08/01/2002 | WO2002058672A2 Microparticles of biodegradable polymer encapsulating a biologically active substance |
| 08/01/2002 | WO2002058671A1 Burst free pharmaceutical microparticules |
| 08/01/2002 | WO2002058670A1 Local anesthetic, and method of use |
| 08/01/2002 | WO2002058669A1 Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids |
| 08/01/2002 | WO2002058668A2 Artificial tear composition adapted to be used with contact lenses |
| 08/01/2002 | WO2002058667A2 Improved process for the production of sustained release drug delivery devices |
| 08/01/2002 | WO2002058666A2 Process for preparing non-hygroscopic sodium valproate composition |
| 08/01/2002 | WO2002058663A1 Method for the production and use of a cream containing vitamin-a. |
| 08/01/2002 | WO2002058622A2 Sn-38 lipid complexes and methods of use |
| 08/01/2002 | WO2002058610A1 Alkyl aryl polyether alcohol polymers for improvement of nasal breathing |
| 08/01/2002 | WO2002058608A1 Loratadine transdermal device and methods |
| 08/01/2002 | WO2002058586A2 Systemic formulations containing beta-carotene and derivatives thereof |
| 08/01/2002 | WO2002058582A2 Anti-carious candies and confections |
| 08/01/2002 | WO2002043657A3 Improved pullulan free edible film compositions and methods of making the same |
| 08/01/2002 | WO2002039992A3 Adducts of quinolonic agents with natural polysaccharide polymers |
| 08/01/2002 | WO2002038646A3 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters |
| 08/01/2002 | WO2002038138A3 Primary packaging for transdermal therapeutic systems or medical plasters |
| 08/01/2002 | WO2002036104A3 Inhalative solution formulation containing a tiotropium salt |
| 08/01/2002 | WO2002035991A3 Spherical particles produced by a hot-melt extrusion/spheronization process |
| 08/01/2002 | WO2002032410A3 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
| 08/01/2002 | WO2002030402A3 Film for active ingredients dermal and transdermal administration |
| 08/01/2002 | WO2002020031A3 Use of erythropoietin and the derivatives of the same for treating schizophrenia and related psychoses |
| 08/01/2002 | WO2002019986A9 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 08/01/2002 | WO2002015876A3 Amorphous carrier materials for drug delivery |
| 08/01/2002 | WO2002014403A3 Acid end group poly(d,l-lactide-co-glycolide) copolymers with high glycolide content |
| 08/01/2002 | WO2002011766A3 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | WO2001089538A3 Apoptotic entities for use in treatment of endothelium dysfunction disorders |
| 08/01/2002 | WO2001089536A3 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders |
| 08/01/2002 | WO2001089319A3 Tryptophan source from plants and uses therefor |
| 08/01/2002 | WO2001085148A3 Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride |
| 08/01/2002 | WO2001083398A3 System for the release of active ingredients |
| 08/01/2002 | WO2001080633A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/01/2002 | WO2001064202A3 Tramadol for the treatment of functional gastrointestinal disorders |
| 08/01/2002 | WO2001062290A3 Methods and compositions for improving sleep |
| 08/01/2002 | WO2001041800A9 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 08/01/2002 | WO2001032232A3 Method of forming micropores in skin |
| 08/01/2002 | WO2001022970A9 Therapy with 2-5a and interferon |
| 08/01/2002 | US20020103517 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 08/01/2002 | US20020103475 Implantable bioartificial active sercretion system |
| 08/01/2002 | US20020103414 Condom with male genital desensitizer lubricant |
| 08/01/2002 | US20020103285 Film coatings and film coating compositions based on polyvinyl alcohol |
| 08/01/2002 | US20020103261 Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals |
| 08/01/2002 | US20020103260 Combinations of formoterol and fluticasone proppionate for asthma |
| 08/01/2002 | US20020103257 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 08/01/2002 | US20020103254 Paclitaxel formulation |
| 08/01/2002 | US20020103232 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 08/01/2002 | US20020103225 Comprises solid amorphous dispersion of compounds such as (2R,4S)4-((3,5-dichloro-benzyl)-methoxycarbonyl-amino)-6,7-dimethoxy-2 -methyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester for elevating plasma lipid levels |
| 08/01/2002 | US20020103219 Mucoadhesive (linear or crosslinked polyacrylic acid, hydroxyalkylcellulose, or dextran sulphate) for drug delivery of antiulcer/antiinflammatory agents |
| 08/01/2002 | US20020103196 Stabilizing pharmaceutical composition by contacting with polymeric material containing an antioxidant; eye drops |
| 08/01/2002 | US20020103181 Specifically betalactam antibiotic, and mixture of sodium alginate and/or xanthan gum, and optionally probenecid as either immediate release or controlled release, in specified weights; once or twice daily dosage |
| 08/01/2002 | US20020103180 Methods, compositions and articles for reducing or preventing the effects of inflammation |
| 08/01/2002 | US20020103179 Soluble contraceptive liquid formulation |
| 08/01/2002 | US20020103175 Use of mometasone furoate for treating airway passage and lung diseases |
| 08/01/2002 | US20020103165 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 08/01/2002 | US20020103162 Use of threo-methylphenidate compounds to enhance memory |
| 08/01/2002 | US20020103158 Dinucleoside polyphosphates which facilitate secretory mechanisms, i.e. increasing the hydration of mucus secretions, stimulating the production of mucins and increasing ciliary beat frequency to facilitate clearance |
| 08/01/2002 | US20020103157 Stimulation of tear secretion by administering uridine 5'-triphosphate dinucleotides, cytidine 5'-triphosphate, adenosine 5'-triphosphate or their useful analogs; enhances mucociliary clearance of nasolacrimal duct |
| 08/01/2002 | US20020103142 Protective, interactive, non-condensing compounds used to prolong localized bioavailability and enhancing expression of a nucleic acid; anticancer agents |
| 08/01/2002 | US20020103113 Oligopeptide lyophilisate, their preparation and use |
| 08/01/2002 | US20020103110 System and method for rectal administration of medication for treatment of migraines |
| 08/01/2002 | US20020102733 Drug delivery system; obtain receptive binding particles, incubate with surface and hydrophilic polymer, incubate with release agent, monitor distribution through biological systems |
| 08/01/2002 | US20020102729 Formulations for electroporation |
| 08/01/2002 | US20020102619 Heparanase specific molecular probes and their use in research and medical applications |
| 08/01/2002 | US20020102336 Blending fruit with an aqueous solution of magnesium hydroxide, an organic acid component and a stabilizer; and drying the fruit to produce a low or nonhygroscopic, dried fruit powder. |
| 08/01/2002 | US20020102315 For therapy of diabetes to be administered perorally in form of tea, a tincture and a pill |
| 08/01/2002 | US20020102312 Molecular imprinting of small particles, and production of small particles from solid state reactants |
| 08/01/2002 | US20020102311 Time-release agents; drug delivery |
| 08/01/2002 | US20020102309 Controlled release formulation for administration of an anti-inflammatory naphthalene derivative |
| 08/01/2002 | US20020102308 For producing protective coatings on drug dosage forms |
| 08/01/2002 | US20020102307 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 08/01/2002 | US20020102306 Soluble form osmotic dose delivery system |
| 08/01/2002 | US20020102305 Osmotic device containing pseudoephedrine and an H1antagonist |
| 08/01/2002 | US20020102304 Initial dose of medicine is capable of achieving a rapid pharmacological effect, whereas a second dose achieves a prolonged pharmacological effect; for use in counteracting cravings for nicotine-containing tobacco products |
| 08/01/2002 | US20020102303 For oral administration; releases the drug in low pH (e.g., gastric fluid) is bioavailable; for therapy of pain |
| 08/01/2002 | US20020102302 Stabilized sustained release tramadol formulations |
| 08/01/2002 | US20020102301 For oral delivery of hydrophobic drugs with low solubility in water |
| 08/01/2002 | US20020102300 Pharmaceuticals formulation |
| 08/01/2002 | US20020102299 Triglyceride reducing agent |
| 08/01/2002 | US20020102298 Temperature-sensitive liposomal formulation |
| 08/01/2002 | US20020102297 Macromolecule-lipid complexes and methods for making and using |
| 08/01/2002 | US20020102296 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 08/01/2002 | US20020102295 Compositions for application to the skin or hair |
| 08/01/2002 | US20020102294 Aerosols comprising nanoparticle drugs |
| 08/01/2002 | US20020102293 Contrast medium that is to be encapsulated in the liposomes is metered such that 5 to 95% by weight of the contrast medium is present in unencapsulated form stabilization |
| 08/01/2002 | US20020102292 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
| 08/01/2002 | US20020102291 For topical application |
| 08/01/2002 | US20020102290 Transdermal preparation containing serotonin receptor antagonist |
| 08/01/2002 | US20020102288 Flexible applicator for applying oil-in-water emulsion with improved stability |
| 08/01/2002 | US20020102286 For use in air fresheners, laundry detergents, fabric softeners, deodorants, lotions |
| 08/01/2002 | US20020102281 Water-soluble concentrate obtained from liquid lipophilic materials of vegetables orgin and at least two ecologically optimized surfactants |
| 08/01/2002 | US20020102280 Solvent systems for pharmaceutical agents |
| 08/01/2002 | US20020102272 Composition for delivery of hematopoietic growth factor |
| 08/01/2002 | US20020102266 Stable vaccine compositions for parenteral administration, a method for their use, and a process for their preparation |
| 08/01/2002 | US20020102236 Liposomal interferon hybrid compositions |
| 08/01/2002 | US20020102219 Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa |
| 08/01/2002 | US20020102218 Stable, aerosolizable suspensions of proteins in ethanol |
| 08/01/2002 | US20020102216 Enhanced ultrasound detection with temperature-dependent contrast agents |
| 08/01/2002 | US20020100476 Apparatus for treatment of chronic obstructive pulmonary disease and associated method |